Tag: tissue factor

Tisotumab Vedotin as Second or Third-Line Therapy for Recurrent Cervical Cancer

byDaniel Goldshteinand1 others

July 15, 2024

1. Median overall survival was 11.5 months in the tisotumab vedotin group and 9.5 months in the chemotherapy group, with ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
2 Minute Medicine Rewind June 30, 2025
Weighted vests and resistance training confer similar outcomes for bone density in the elderly

No Result

View All Result